Laserfiche WebLink
State of California-Health and Welfare Agency Department of Health Services <br /> Page 6 of 7 pages <br /> RADIOACTIVE MATERIAL LICENSE License Number: 1276-39 <br /> Supplementary Sheet Amendment Number: 62 <br /> 27. Radioactive materials prepared, processed, or modified by the licensee shall not be administered to humans <br /> except as specifically authorized by this license. <br /> 28. The licensee shall elute generators and process radioactive material with reagent kits in accordance with <br /> instructions furnished by the manufacturer on the label attached to or in the leaflet or brochure that accompanies <br /> the generator or reagent kit. <br /> 29. Technetium 99m labelled pharmaceuticals prepared by the licensee by aseptic addition of pertechnetate to <br /> sterile, pyrogen free reagents may be administered to humans provided the radioassay of the final product is <br /> determined with an overall error not exceeding ten percent. When the pharmaceutical is prepared from reagents <br /> procured in the form of approved kits, the licensee must strictly follow all instructions and recommendations <br /> contained in the package insert information; otherwise the pharmaceutical must be prepared and compounded <br /> from a prescription in accordance with the regulations of the California Board of Pharmacy. <br /> 30. For a period not to exceed 60 days in any calendar year, a visiting physician is authorized to use licensed <br /> materials for human use under the terms of this license, provided the visiting physician: <br /> (a) Has the prior written permission of the hospital's Administrator and its Radiation Safety Committee. <br /> (b) Is specifically named as a user on an Nuclear Regulatory Commission(NRC) or Agreement State license <br /> authorizing human use. <br /> (c) Performs only those procedures for which the physician is specifically authorized by the Nuclear <br /> Regulatory Commission(NRC) or Agreement State license. <br /> The licensee shall maintain for inspection copies of the written permission specified in (a) above and the <br /> license(s) specified in (b) and (c) above. These records shall be maintained for five years from the time the <br /> licensee grants its permission under (a) above. <br /> 31. Equipment for radiometric assay of pharmaceuticals, body fluids, excreta, or in-vitro assay samples shall be <br /> calibrated to ensure reliability of data obtained. The stability of the equipment shall be checked at least once <br /> each day of use, using appropriate standards. <br /> 32. Nuclear medicine technology procedures shall be performed by nuclear medicine technologists pursuant to the <br /> California Code of Regulations, Title 17, Subchapter 4.6. Such procedures shall be performed under the <br /> supervision of individuals listed as authorized users on this license who meet the criteria specified in Section <br /> 30510. Certificates or special permits issued pursuant to Subchapter 4.6 shall be prominently displayed at the <br /> facility authorized on this license. <br /> 33. This license does not authorize commercial distribution of radioactive material. <br /> 34. Production or processing of radiopharmaceuticals for the purpose of distribution to other licensees is not <br /> authorized by this license. <br />